Skip to main content

Table 2 Within-patient distribution of E. faecium isolates

From: Dynamics of ampicillin-resistant Enterococcus faecium clones colonizing hospitalized patients: data from a prospective observational study

 

Hematology UHBS

ICU UMCU

 

Group 1a

Group 1b

Group 2

Patients, n

33

21

25

- with ARE, n (%)

13 (40%)

3 (14%)

21 (84%)

- with only ASE, n (%)

9 (27%)

9 (43%)

2 (8%)

- with no E. faecium, n (%)

11 (33%)

9 (43%)

2 (8%)

Patients with only one MT of ARE

   

- MT159

1

2

9

- Other ARE

3

0

3

Patients with replacementsa of E. faecium

   

- ASE to ARE

6

0

0

- ARE to ASE

1

0

2

- ARE change of MT

2

1

7

  1. UHBS University Hospital Basel; ICU Intensive Care Unit; UMCU University Medical Center Utrecht; ARE ampicillin-resistant E. faecium; ASE ampicillin-susceptible E. faecium a Replacement of an ampicillin-susceptible by an ampicillin-resistant clone in consecutive swab or vice versa or replacement of an ARE by a different ARE MT clone